JP2016516072A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016516072A5 JP2016516072A5 JP2016503369A JP2016503369A JP2016516072A5 JP 2016516072 A5 JP2016516072 A5 JP 2016516072A5 JP 2016503369 A JP2016503369 A JP 2016503369A JP 2016503369 A JP2016503369 A JP 2016503369A JP 2016516072 A5 JP2016516072 A5 JP 2016516072A5
- Authority
- JP
- Japan
- Prior art keywords
- contrast medium
- formulation
- enteric
- intestinal
- poly
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002872 contrast media Substances 0.000 claims 27
- 238000009472 formulation Methods 0.000 claims 12
- 239000000203 mixture Substances 0.000 claims 12
- 230000000968 intestinal effect Effects 0.000 claims 8
- 238000000034 method Methods 0.000 claims 7
- 239000011248 coating agent Substances 0.000 claims 5
- 238000000576 coating method Methods 0.000 claims 5
- 238000011177 media preparation Methods 0.000 claims 5
- 229920000642 polymer Polymers 0.000 claims 5
- 239000000463 material Substances 0.000 claims 4
- 239000002245 particle Substances 0.000 claims 4
- 229940039231 contrast media Drugs 0.000 claims 3
- 210000001035 gastrointestinal tract Anatomy 0.000 claims 2
- 150000007524 organic acids Chemical class 0.000 claims 2
- 235000005985 organic acids Nutrition 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 239000003981 vehicle Substances 0.000 claims 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims 1
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- 229920002873 Polyethylenimine Polymers 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 150000001298 alcohols Chemical class 0.000 claims 1
- 150000001412 amines Chemical class 0.000 claims 1
- 239000012736 aqueous medium Substances 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 150000001642 boronic acid derivatives Chemical class 0.000 claims 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000000084 colloidal system Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 230000018044 dehydration Effects 0.000 claims 1
- 238000006297 dehydration reaction Methods 0.000 claims 1
- 239000000412 dendrimer Substances 0.000 claims 1
- 229920000736 dendritic polymer Polymers 0.000 claims 1
- 239000000839 emulsion Substances 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 239000010419 fine particle Substances 0.000 claims 1
- 239000000796 flavoring agent Substances 0.000 claims 1
- 235000013355 food flavoring agent Nutrition 0.000 claims 1
- 150000004676 glycans Chemical class 0.000 claims 1
- 239000000017 hydrogel Substances 0.000 claims 1
- 150000004679 hydroxides Chemical class 0.000 claims 1
- 238000003384 imaging method Methods 0.000 claims 1
- 229910052740 iodine Inorganic materials 0.000 claims 1
- 239000011630 iodine Substances 0.000 claims 1
- 239000002609 medium Substances 0.000 claims 1
- 210000000214 mouth Anatomy 0.000 claims 1
- 239000002105 nanoparticle Substances 0.000 claims 1
- 229920001542 oligosaccharide Polymers 0.000 claims 1
- 150000002482 oligosaccharides Chemical class 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 239000006179 pH buffering agent Substances 0.000 claims 1
- 235000021317 phosphate Nutrition 0.000 claims 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 claims 1
- -1 poly (siloxane) Polymers 0.000 claims 1
- 229920000233 poly(alkylene oxides) Polymers 0.000 claims 1
- 229920001308 poly(aminoacid) Polymers 0.000 claims 1
- 229920000058 polyacrylate Polymers 0.000 claims 1
- 229920001282 polysaccharide Polymers 0.000 claims 1
- 239000005017 polysaccharide Substances 0.000 claims 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 1
- 210000000664 rectum Anatomy 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 239000011593 sulfur Substances 0.000 claims 1
- 238000001356 surgical procedure Methods 0.000 claims 1
- 239000000375 suspending agent Substances 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 239000002562 thickening agent Substances 0.000 claims 1
- 210000003708 urethra Anatomy 0.000 claims 1
- 210000003932 urinary bladder Anatomy 0.000 claims 1
- 210000001215 vagina Anatomy 0.000 claims 1
- 229920002554 vinyl polymer Polymers 0.000 claims 1
- 229920003169 water-soluble polymer Polymers 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361790734P | 2013-03-15 | 2013-03-15 | |
| US201361798392P | 2013-03-15 | 2013-03-15 | |
| US61/790,734 | 2013-03-15 | ||
| US61/798,392 | 2013-03-15 | ||
| PCT/US2014/030295 WO2014145509A1 (en) | 2013-03-15 | 2014-03-17 | Enteric ct contrast material based on low-z atoms |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018038401A Division JP6843787B2 (ja) | 2013-03-15 | 2018-03-05 | 低ｚ原子による腸管ｃｔ造影材料 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016516072A JP2016516072A (ja) | 2016-06-02 |
| JP2016516072A5 true JP2016516072A5 (enExample) | 2017-04-20 |
Family
ID=51530440
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016503369A Pending JP2016516072A (ja) | 2013-03-15 | 2014-03-17 | 低ｚ原子による腸管ｃｔ造影材料 |
| JP2018038401A Active JP6843787B2 (ja) | 2013-03-15 | 2018-03-05 | 低ｚ原子による腸管ｃｔ造影材料 |
| JP2020144080A Pending JP2020193223A (ja) | 2013-03-15 | 2020-08-28 | 低ｚ原子による腸管ｃｔ造影材料 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018038401A Active JP6843787B2 (ja) | 2013-03-15 | 2018-03-05 | 低ｚ原子による腸管ｃｔ造影材料 |
| JP2020144080A Pending JP2020193223A (ja) | 2013-03-15 | 2020-08-28 | 低ｚ原子による腸管ｃｔ造影材料 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11033640B2 (enExample) |
| EP (2) | EP3984560A1 (enExample) |
| JP (3) | JP2016516072A (enExample) |
| CN (2) | CN108743976B (enExample) |
| ES (1) | ES2897624T3 (enExample) |
| WO (1) | WO2014145509A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108743976B (zh) | 2013-03-15 | 2021-10-29 | 加利福尼亚大学董事会 | 基于低-z原子的肠ct造影材料 |
| US20160193366A1 (en) | 2013-08-16 | 2016-07-07 | The Regents Of The University Of California | Silicone-based enteric ct contrast material |
| PL3285743T3 (pl) | 2015-04-20 | 2021-12-06 | The Regents Of The University Of California | Kapsułkowany gaz lub częściowa próżnia środka kontrastowego w tomografii komputerowej |
| US20200179539A1 (en) * | 2016-06-22 | 2020-06-11 | Board Of Regents, The University Of Texas System | Contrast Agents and Methods of Making the Same for Spectral CT That Exhibit Cloaking and Auto-Segmentation |
| AU2017371069C1 (en) | 2016-12-08 | 2025-02-27 | Centre National De La Recherche Scientifique | Bismuth-gadolinium nanoparticles |
| CN109100775B (zh) * | 2018-07-06 | 2020-05-29 | 郑州云海信息技术有限公司 | 一种双层探测器的能量谱校正方法与装置 |
| JP2020103571A (ja) * | 2018-12-27 | 2020-07-09 | キヤノンメディカルシステムズ株式会社 | 医用処理装置及びｘ線診断システム |
| KR20240024802A (ko) * | 2021-05-05 | 2024-02-26 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | X선 감쇠 변화가 적은 하드쉘형 경구 조영제 |
| WO2024086131A1 (en) * | 2022-10-18 | 2024-04-25 | The Johns Hopkins University | Systems and methods for angiography using multi-energy detectors |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3592185A (en) | 1967-04-18 | 1971-07-13 | Yeda Res & Dev | Ferromagnetic contrast media and method of use |
| US4615879A (en) * | 1983-11-14 | 1986-10-07 | Vanderbilt University | Particulate NMR contrast agents for gastrointestinal application |
| JPS6238172A (ja) | 1985-08-12 | 1987-02-19 | 株式会社 高研 | 抗血栓性医用材料の製造方法 |
| DE3709851A1 (de) * | 1987-03-24 | 1988-10-06 | Silica Gel Gmbh Adsorptions Te | Nmr-diagnostische fluessigkeitszusammensetzungen |
| IL82834A (en) | 1987-06-09 | 1990-11-05 | Yissum Res Dev Co | Biodegradable polymeric materials based on polyether glycols,processes for the preparation thereof and surgical artiicles made therefrom |
| GB9006671D0 (en) | 1990-03-24 | 1990-05-23 | Univ Manchester | Diagnostic method and compositions |
| US5205290A (en) | 1991-04-05 | 1993-04-27 | Unger Evan C | Low density microspheres and their use as contrast agents for computed tomography |
| SE9101709L (sv) * | 1991-06-03 | 1992-12-04 | Karlshamns Lipidteknik Ab | Lipidderivat som diagnostikum eller kontrastmedel |
| US5323780A (en) | 1992-08-07 | 1994-06-28 | University Of Florida Research Foundation, Inc. | Artifact-free imaging contrast agent |
| US5472682A (en) | 1993-03-31 | 1995-12-05 | Sterling Winthrop Inc. | Compositions of iodophenyl esters and iodophenyl sulfonates and pharmaceutically acceptable clays for visualization of the gastrointestinal tract |
| US5318769A (en) | 1993-03-31 | 1994-06-07 | Sterling Winthrop Inc. | Compositions of iodophenyl esters for X-ray visualization of the gastrointestinal tract |
| AU1816395A (en) | 1994-02-25 | 1995-09-11 | Nycomed Imaging As | X-ray contrast compositions containing cellulose derivatives |
| WO1995028969A1 (en) | 1994-04-21 | 1995-11-02 | Nycomed Imaging As | X-ray contrast compositions containing pharmaceutically acceptable clays |
| US5736121A (en) | 1994-05-23 | 1998-04-07 | Imarx Pharmaceutical Corp. | Stabilized homogenous suspensions as computed tomography contrast agents |
| US6818199B1 (en) * | 1994-07-29 | 2004-11-16 | James F. Hainfeld | Media and methods for enhanced medical imaging |
| US5580579A (en) * | 1995-02-15 | 1996-12-03 | Nano Systems L.L.C. | Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers |
| GB9603547D0 (en) * | 1996-02-20 | 1996-04-17 | Nycomed Imaging As | Contrast media |
| ATE276745T1 (de) * | 1998-04-09 | 2004-10-15 | Amersham Health As | Verwendung von teilchenförmigen kontrastmitteln in der diagnostischen bilderzeugung zur untersuchung physiologischer parameter |
| NO20052429D0 (no) * | 2005-05-20 | 2005-05-20 | Amersham Health As | Konstrastmidler |
| GB0519391D0 (en) | 2005-09-22 | 2005-11-02 | Aion Diagnostics Ltd | Imaging agents |
| US20070258907A1 (en) * | 2006-04-24 | 2007-11-08 | Davis Mark E | Polymer-coated paramagnetic particles |
| EP2127682A1 (en) * | 2008-05-28 | 2009-12-02 | Deutsches Krebsforschungszentrum | X-ray contrast agent based on bismuth oxide-nanoparticles |
| JP2014501235A (ja) | 2010-12-13 | 2014-01-20 | ノバルティス アーゲー | 二量体ｉａｐ阻害剤 |
| CA2819795A1 (en) | 2010-12-15 | 2012-06-21 | General Electric Company | Nanoparticle composition and associated methods thereof |
| US9757480B2 (en) * | 2011-01-28 | 2017-09-12 | Abk Biomedical Incorporated | Radiopaque embolic particles |
| EP2717934A4 (en) | 2011-06-06 | 2015-01-14 | Oregon State | X-RAY CONTRACTS FROM WISMUT PARTICLES |
| EP2854868A4 (en) * | 2012-06-04 | 2016-01-20 | Migrata U K Ltd | MEDICAL USE OF TITANIUM PARTICLES AND / OR TITANIUM OXIDE |
| CN108743976B (zh) | 2013-03-15 | 2021-10-29 | 加利福尼亚大学董事会 | 基于低-z原子的肠ct造影材料 |
| US20160193366A1 (en) * | 2013-08-16 | 2016-07-07 | The Regents Of The University Of California | Silicone-based enteric ct contrast material |
-
2014
- 2014-03-17 CN CN201810611475.2A patent/CN108743976B/zh active Active
- 2014-03-17 CN CN201480022822.8A patent/CN105142680A/zh active Pending
- 2014-03-17 JP JP2016503369A patent/JP2016516072A/ja active Pending
- 2014-03-17 ES ES14764088T patent/ES2897624T3/es active Active
- 2014-03-17 WO PCT/US2014/030295 patent/WO2014145509A1/en not_active Ceased
- 2014-03-17 EP EP21190284.6A patent/EP3984560A1/en active Pending
- 2014-03-17 EP EP14764088.2A patent/EP2968619B1/en active Active
- 2014-03-17 US US14/215,827 patent/US11033640B2/en active Active
-
2018
- 2018-03-05 JP JP2018038401A patent/JP6843787B2/ja active Active
-
2020
- 2020-08-28 JP JP2020144080A patent/JP2020193223A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Maisel et al. | Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse | |
| Poinard et al. | Polydopamine coating enhances mucopenetration and cell uptake of nanoparticles | |
| Oshi et al. | Colon-targeted dexamethasone microcrystals with pH-sensitive chitosan/alginate/Eudragit S multilayers for the treatment of inflammatory bowel disease | |
| Cho et al. | In vivo tumor targeting and radionuclide imaging with self-assembled nanoparticles: mechanisms, key factors, and their implications | |
| Cu et al. | Controlled surface modification with poly (ethylene) glycol enhances diffusion of PLGA nanoparticles in human cervical mucus | |
| Luo et al. | Encapsulation of Escherichia coli strain Nissle 1917 in a chitosan―alginate matrix by combining layer-by-layer assembly with CaCl2 cross-linking for an effective treatment of inflammatory bowel diseases | |
| JP2022003054A (ja) | カプセル化された気体または部分真空のｃｔ造影材料 | |
| US9597419B2 (en) | Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same | |
| Cook et al. | Microencapsulation of a synbiotic into PLGA/alginate multiparticulate gels | |
| JP2015519330A5 (enExample) | ||
| US20080243113A1 (en) | Modification of stent surfaces to impart functionality | |
| Lim et al. | Current status and advances in esophageal drug delivery technology: influence of physiological, pathophysiological and pharmaceutical factors | |
| CN110408047B (zh) | 纳米配位聚合物及其制备方法和应用 | |
| JP6846351B2 (ja) | 粘膜表面における活性薬剤の増強された輸送のための低張ヒドロゲル製剤 | |
| CN103120795B (zh) | 一种靶向巨噬细胞的制剂 | |
| Go et al. | A soft biodegradable chitosan‐based medical microrobot with optimized structural design and X‐ray visibility for targeted vessel chemoembolization | |
| Lee et al. | Drug‐loaded mucoadhesive patch with active delivery and controlled releasing ability | |
| JP2018090624A (ja) | 低ｚ原子による腸管ｃｔ造影材料 | |
| WO2015127389A1 (en) | Hypotonic enema formulations and methods of use | |
| Ali et al. | Advances in nanoparticles as anticancer drug delivery vector: need of this century | |
| Zhao et al. | Oral delivery of ultra-small zwitterionic nanoparticles to overcome mucus and epithelial barriers for macrophage modulation and colitis therapy | |
| Enwereuzo et al. | Self-assembled membrane-polymer nanoparticles of top-notch tissue tolerance for the treatment of gastroesophageal reflux disease | |
| Fathi Kisomi et al. | Unveiling the potential role of micro/nano biomaterials in the treatment of Helicobacter pylori infection | |
| Kabha et al. | Biodegradable controlled-release device for localized chemotherapeutic treatment of bladder cancer | |
| ES2670925T3 (es) | Agente de contraste para IRM que contiene partículas de material compuesto |